CareerPlan

Director, Clinical Research- Benign Hematology

CambridgeFull-time2026-11-10 → 2026-11-19
Hybrid

Core

Lead clinical development for RNAi therapeutics in benign hematology, transitioning a plasminogen program from Phase 2 to Phase 3.

Role type

Director, Clinical Research (Physician-Scientist)

Builds

Global clinical trials for RNAi drugs targeting rare and common genetic diseases

Domain

Biotechnology / RNAi therapeutics / Hematology

Required skills

Clinical trial leadership, regulatory strategy, cross-functional collaboration, scientific judgment, document review/sign-off, external stakeholder influence

Preferred skills

Board certification in hematology, MD/PhD, peer-reviewed publication history

Technologies

RNAi therapeutics, clinical trial management systems, regulatory submission platforms

Responsibilities

Provide strategic clinical leadership for the plasminogen program; oversee trial conduct and safety; collaborate with preclinical, regulatory, and medical affairs teams; supervise major written deliverables and sign off on controlled documents; represent the program at external regulatory and scientific meetings.

Seniority

Director, strategic leadership with hands-on clinical oversight